Two drugs that looked like promising treatments for COVID-19 in preliminary studies – remdesivir for hospitalized patients and camostat for patients who are not seriously ill – failed to show a benefit in those groups in randomized controlled trials, researchers reported in two separate papers. In five European countries, researchers […]
Though overall COVID-19 case counts continue to drop nationally, that’s not the story in every U.S. state. About half the states have reported increases in COVID cases fueled by the Omicron subvariant, Axios reported. Alaska, Vermont, and Rhode Island had the highest increases, with more than 20 new cases per 100,000 […]
Antibiotics are ineffective treatment for viral syndromes, including COVID-19. We characterized antibiotic prescribing in older adults with outpatient COVID-19 visits to identify opportunities to improve prescribing practices. Methods We used 100% Medicare carrier claims and Part D event files to identify beneficiaries with a COVID-19 outpatient visit and associated antibiotic […]
Federal regulators have announced that GlaxoSmithKline’s COVID-19 drug should no longer be used because it’s likely ineffective against BA.2, the Omicron subvariant that now accounts for most new cases in the United States, The Associated Press reports. The Food and Drug Administration announced that the antibody drug sotrovimab is no longer authorized to […]
Ha quedado demostrado que tras pasar la enfermedad del Covid-19, se forman anticuerpos que protegen de la enfermedad. Sin embargo, estos anticuerpos tienen un tiempo establecido de duracion. Los anticuerpos contra el Covid-19 se vuelven indetectables en las pruebas serológicas en un 43,3% de los pacientes transcurridos siete meses desde la infección, según […]
NORFOLK, Va. (AP) — COVID-19 hospitalization numbers have plunged to their lowest levels since the early days of the pandemic, offering a much needed break to health care workers and patients alike following the omicron surge. The number of patients hospitalized with the coronavirus has fallen more than 90% in […]
MADRID, ESP. Las personas con un trastorno por consumo de sustancias presentan un riesgo más elevado de infectarse y de fallecer a causa de la COVID-19 que la población general, incluso habiendo recibido la pauta vacunal completa. Así lo ha demostrado una línea de investigación liderada por la psiquiatra mexicana […]
The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is unclear. METHODS We conducted a double-blind, randomized, placebo-controlled, adaptive platform trial involving symptomatic SARS-CoV-2–positive adults […]
Here’s why it matters. The risk for pneumococcal disease rises with age, with the highest risk among those aged 65 or older and younger adults with chronic medical or immunocompromised conditions. These groups carry more than 90% of the burden of invasive pneumococcal disease in adults. Invasive pneumococcal disease (IPD) includes meningitis, bacteremia, and […]
Even mild cases of COVID-19 are associated with brain changes including decreased gray matter, an overall reduction in brain volume, and cognitive decline, a new imaging study shows. In the first study to use magnetic resonance brain imaging, before and after COVID-19, investigators found “greater reduction in grey matter thickness […]
